MK-6916
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-6916, covering 2025-08-26 to 2025-08-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005) [Phase 1]